AZoSensors speaks with Jesse Jokerst who heads up the Jokerst group at UC San Diego. The group has recently developed an affordable COVID-19 monitoring sensor that can be applied to facemasks. The team’s research has benefitted from a $1.3 million investment from the National Institutes of Health as part of the NIH’s Rapid Acceleration of…
Scientists suggest the vampire finch evolved to drink blood to survive the volcanic archipelago’s harsh environment and scarce resources
Thursday: The University of California’s new president, Dr. Michael Drake, discusses testing and sports.
The immune systems of some people who have not been exposed to the novel coronavirus could have some familiarity with the pathogen — possibly helping to reduce the severity of illness if that person does get Covid-19, a new study suggests.
According to Mary Poppins, a spoonful of sugar helps the medicine go down. In the case of coronavirus, a cloak of sugar helps the virus infect. This sugary-coating disguise, made of molecules called glycans, tricks the human immune system into identifying the microbe as harmless. The resulting recognition failure keeps the body from generating the…
Science is continuing to shine a light on the links between gut bacteria and all kinds of health conditions, ranging from depression, to autoimmune disease, to Alzheimer’s and PTSD. A US research team working to further unravel its secrets has happened upon a specific signature of gut bacterial species, which it found could be used…
UC San Diego Center for Microbiome Innovation Adds Two Petabytes of Panasas HPC Storage for COVID-19 Research
CMI Partner, Panasas, storage expansion clears the way for sequencing massive amounts of genomic data that could hold clues to how coronavirus spreads? and how it could be cured
Combining surfing and science to understand more about our microbiome
The coronavirus is covered in a sugary exterior which makes it hard for the body to fight against it. UC San Diego chemists have zoomed in the coronavirus and uncovered a detailed picture of this shield, so that vaccine and antiviral developers can find ways to get through it.
During the induction period, patients in the treatment group had higher incidences of infections and serious infectious compared to placebo.